Tun hnaia Las Vegas-a SupplySide Global 2025 neih zawh takah khan hmeichhiate hriselna leh hormone balance chu show-a thupui lar ber pawlah a lang chhuak a ni.
He event sponsor zinga mi a nih angin,Bonerge chuan a ti a, industry lama mithiam lar tak tak leh PhD zirchiangtute nen tangkawpin keynote session pathum an nei a, personalized nutrition hunlai hian life-stage transition leh biochemical individuality-in a awm theihna tur hun remchang ropui tak takte an zirchiang a ni.
He thuziak hian kan nghahhlelh em em keynote a\\angin a hmang a ni"Life Stages & Body Chemistry: Gender-Specific Biochemical Change chungchanga thlah kal zel thlirna"., hmeichhe hriselna market-a hmalam hun thlirletna thuk tak leh Bonerge-i strategic direction te a pe a ni.
I. "Multi-Billion-Dollar Blind Spot"-ah Kan Ding A.
Session hi hriatthiamna hmuhnawm tak nen hawn a ni a:
Vitamin leh minerals-kan thiam tawh a, mahse a lian zawk chu kan hloh ta a ni.
Vawiin,Dietary supplement 85% chu general-purpose formulation a la ni reng a ni, hmeichhia leh mipa hi biochemical realities bulpuiah chuan a inang lo hle chung pawhin. Nunna-stage inthlak danglamna-a bik takin hmeichhiaah hormone inthlak danglamna-chuan vulnerability windows predictable sang tak a siam thin.
📊 US dietary supplement market-ah chuan gender-specific products hian hralhna 50% a luah tawh a, USD tluklehdingawn 68 a tling tawh a ni [1].
Tu2035:
Hmeichhe health supplement category chu a pung chho dawn a niUSD 5.3B → 8.6B a ni
Menopause market hi a zau chho zel dawn a niUSD 1.8B → 2.8B [2,3] a ni.
➡️ Hei hian USD tluklehdingawn 34 zeta seng, underdeveloped segment a entir a ni-kan tih hi a"multi-billion maktaduai tam tak mitdel."
II. Hmeichhe Biochemical Journey: "Hormonal Roller Coaster" Tuman An Hriatthiam Loh
Hmeichhe taksa hi a dam chhung zawnga hormone inthlak danglamna-puberty atanga post{1}}menopause thlenga symphony a ni.
Transition tin hian hriselna atana hlauhawm leh market opportunity a keng tel vek a ni.
▌Kum 20–30: Naupai theihna sang ber, PCOS hlauhawmna sang ber
🔄 Hormone awm dan (Hormone profile) a ni: Estrogen & progesterone cycle inthlak danglamna [4] .
🔄 Hriselna lama harsatna awm thei: PMS, PCOS (hmeichhia reproductive-age zinga 6–13% vel a nghawng) [5] .
🔄 Market-a thil awm thei te: Hormone balance, nau neih theihna tur support
▌Kum 40–50: Perimenopause-"Early Warning Stage" tih hi a ni.
🔄 Hormone awm dan (Hormone profile) a ni: FSH hi 30 → 70–90 IU/L aṭangin a sang chho a; estrogen hi nasa takin a inthlak danglam thin [6] .
🔄 Hriselna lama harsatna awm thei: Hot flashes, mut theih lohna, mood instability, metabolic slowdown
🔄 Market-a thil awm thei te: Transition-phase support, multi-symptom formula hrang hrang
▌Kum 60+: Post-Menopause-"Risk Accumulation Stage" tih hi a ni.
🔄 Hormone awm dan (Hormone profile) a ni: Estrogen hi premenopausal level atanga 1–8% aia hniam a ni [7].
🔄 Hriselna lama harsatna awm thei: He phase-ah hian dam chhunga ruh hloh 20% thleng a thleng a; metabolic risk a sang chho zel [8] .
🔄 Market-a thil awm thei te: Ruh hriselna, metabolic support
III. Stress Responses: A Thinrim laiin a lungkham chhan
Thusawi sawina hmun êng tak pakhatstress chungchanga neuroscience a ni.
Mipa leh hmeichhia an activatebiochemical system hrang hrang vek a nistress hnuaiah [9]:
Mipa: 1.1.
Indona-or-thlawhna → Testosterone + vasopressin
→ Thisen sang a sang
→ Focus tihsan a ni
→ Cardiovascular load tihpun
Hmeichhia:
Tend-leh-inhmelhriat → Oxytocin + estrogen
→ Khawtlang nun inzawmna
→ Emotional processing (Emotional processing) a ni
→ Anxiety & depression neih theihna a sang zawk
➡️ A awmzia chu:
Mipa mamawhcortisol-testosterone balance + rilru leh thisen kalna-protective adaptogens
Hmeichhiaten an mamawhoxytocin-pathway support, mood stabilizer, leh cycle-synchronized formula te a awm bawk
🎯 Bonerge Hriatthiamna:
Nakin lawka formulations te chu a ni tur a nimipa leh hmeichhia-specific, "pakhat-size-fit-mi zawng zawng" ni lovin.
IV. Hlawhtlinna: Brand Hruaitute’n Dollar Market Billion-An Unlock Dan
▌ZenovaTM - Ovarian Aging tidanglamtu
Cepham (Bonerge-a strategic partner) atanga patented fenugreek chi extract, Ayurvedic science atanga zung kai.
💎 Chona:Ovarian aging hi insulin resistance & hormonal imbalance nen a inzawm a ni
💎 Chingchhuak:Glucose metabolism & hormone balance tihreh dan dual-action
💎 Rahchhuak:
Ovarian cyst 70% a tlahniam(clinical data) a ni.
Final-ah Vitafoods 2016 Awards a dawng tawh bawk
▌SheVari4® - Menopause enkawlna atana hmanraw tha tak
A advanced extract atanga lak chhuah a niShatavari (Asparagus racemosus) a ni a, a hring hring a ni.-SupplySide Global 2025-a breakout ingredient a ni.
💎 Chona:Kum tin hmeichhia maktaduai 50 velin menopause an lut thin a; 75% chuan symptoms langsar tak tak an nei
💎 Chingchhuak:Standardized extraction + third-party verification + multi-symptom targeting tih a ni
💎 Rahchhuak: 85% chuan symptom a ti tha zawk, USD 600M segment chak tak-pung chak tak a man
▌EquoYouthTM - Hormone Balance lama hmasawnna
Bonerge-a thil siam chhuah zingah chuan:S-Equol, equol-a biologically active enantiomer awmchhun a ni.
Via siam chhuah a nipatented fermentation hmanga siam a ni
99% thianghlimna a ni
Hmasa berSA-GRAS–certified a nihigh-purity S-Equol khawvel pumah
💎 Chona:Gender-targeted immune & hormonal support products tlakchhamna nasa tak
💎 Chingchhuak:ER -selective activity a tichakbidirectional estrogen tihregulate a ni
💎 Rahchhuak:Hormone-balancing nutraceuticals atana standard thar siam a ni
▌BeFisetin® - Mipa Nau neihna chu a bulpui berah a thlawp
Kum upa lam-related reproductive decline target tu Senolytic ingredient.
💎 Chona:Kum 50 kalta chhung khan Sperm quality 50% zetin a tlahniam a
💎 Chingchhuak:Patent hmanga lakchhuah, 100% natural, clinically supported a ni
💎 Rahchhuak:SA-GRAS certified + clinical evidence pahnih nei
V. Nakin hun atana "Goldmine" Hun remchang Pali
Keynote-ah hian high-value market pali, a tam zawk hman loh a ni tih hmuhchhuah a ni [17]:
🧍 ♂️ Mipa nau neih theihna (USD 1.6B) .- sperm quality chu kum 50 chhungin 50% in a tlahniam
🧠 Mipa tar tawhte tan hriatna (cognitive health).- risk sang tak, targeted product awm lo tluk zet
🚺 Hmeichhia autoimmune support (USD 2.3B) .- prevalence chu mipa aiin 3× in a sang zawk
🌸 Perimenopause (kum 5–10 chhung window) .- hian hmeichhia 47M a nghawng a; 3% chauhvin target solution an nei
VI. Thutawp: Nutrition hmalam hun hi Mimal a ni
Kum 25-hmeichhia ≠ Kum 45-mipa ≠ Kum 65 mi, postmenopausal hmeichhia.
Kan shift ta a niuniversal nutrition → precision, nun-stage, mipa leh hmeichhia-specific nutrition.
Hmeichhia leh mipa inthlauhna=product opportunity
Nunna-stage inthlak danglamna=intervention windows
Scientific gaps=market hlawkna
Bonerge hian gender- leh life-stage-specific nutrition chu a ti hmasawn zel dawn a, industry pumpuiah thawhhona tha tak neiin precision health hun thar a hawng dawn a ni.
Thuhmahruai:
[1] Grand View zirchianna2024, 2024.https://www.grandviewresearch.com/ ah hian a awm bawk.
[2] Hmalam hun atana Market Insights 2025, 2025.https://www.nakin lawka marketinsights.com/ ah hian a awm a.
[3] Straits zirchianna 2024, 2024-a thil thlengte.https://straitsresearch.com/ ah hian a awm a ni.
[4] Cleveland Clinic, 1999-ah a awm a.A rilru a hah lutuk chuan a rilru a buai em em a, a rilru a hah lutuk chuan a rilru a buai em em bawk a. 22353-estrogen
[5] WHO, .https://www.who.int/news-room/fact-sheet/detail/polycystic-ovary-syndrome a awm a, a natna hi a lar hle
[6] Penn Psychiatry, 1999-ah a awm a.https://www.med.upenn.edu/hmeichhe hrisel lohna/menopause.html
[7] Hmeichhia in Balance Institute, 2019.https://womeninbalance.org/2025/06/24/a pangngai-estradiol-level-kum-a zirin/
[8] Endocrine Society, 1999-ah a awm a.https://www.endocrine.org/patient-engagement/endocrine-library/menopause-leh-ruh-bo
[9] Stress chungchanga neuroscience, 1999.A rilru a hah lutuk chuan a rilru a buai em em a. 10.1007/978-3-031-00864-1
[10] Cepham, 1999 a ni.https://cepham.com/a siam chhuah/branded/ tihchhuah a ni.
[11] Cepham, 1999 a ni.A rilru a hah lutuk chuan a rilru a buai em em a, a rilru a hah lutuk chuan a rilru a buai em em bawk a.SheVari4-Sell-Sheet_022024-1.pdf
[12]Kuiper GG, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, Gustafsson JA te chuan an ziak a. Estrogen receptor alpha leh beta te ligand binding specificity leh transcript tissue distribution te khaikhin a ni. Endocrinology. 1997 Mar;138(3):863-70 chhunga zir chhuah a ni.
[13]Setchell KD, Clerici C, Lephart E. D., leh a dangte chuan an ziak a. Estrogen receptor beta tana ligand chak tak S-equol hi mihring intestinal bacterial flora siam soy isoflavone metabolite enantiomeric form bik a ni. A rilru a hah lutuk chuan a rilru a buai em em a. 1072-1079.
[14]Ishiwata N, Melby MK, Mizuno S, leh a dangte chuan an ziak a. Menopausal symptoms tihziaawmna atana equol supplement thar: Japanese hmeichhiate randomized, placebo-controlled trial. Menopause. 2009;16(1):141-8 ah chuan a chhuak leh ta.
[15] Choi EJ, Kim T. Equol hian mihring hnute cancer MDA-MB-453-ah cell cycle arrest hmangin apoptosis a thlen a, mahse MCF-7 cell-ah erawh a tichhuak lo. Mol Med Rep. 2008;1(2):239-44-ah a rawn lang leh ta.
[16] Yousefzadeh MJ, Zhu Y, McGowan SJ, leh a dangte chuan an ziak a. Fisetin hi senotherapeutic a ni a, hriselna leh dam chhung a ti rei a ni. EBioMedicine. 2018;36:18-28 ah hian a awm a. A rilru a hah lutuk chuan a rilru a buai em em a. 10.1016/j.ebiom.2018.09.015.
[17] NUNNA STAGE & PHASES: TAKSA CHEMISTRY, NUN-STAGES-leh-PHASES-TAKSA-CHEMISTRYVer02.pptx
